Histone deacetylase inhibitors and periodontal bone loss.

Cantley, M D; Bartold, P M; Marino, V; Fairlie, D P; Le, G T; Lucke, A J; Haynes, D R

Cantley, M D; Bartold, P M; Marino, V; Fairlie, D P; Le, G T; Lucke, A J; Haynes, D R.

Affiliation

Cantley MD; Discipline of Anatomy and Pathology, School of Medical Sciences, University of Adelaide, Adelaide, SA, Australia.

J Periodontal Res ; 46(6): 697-703, 2011 Dec.

Article in En | MEDLINE | ID: mdl-21745207

Subject(s)

Alveolar Bone Loss/enzymology; Alveolar Bone Loss/prevention & control; Histone Deacetylase Inhibitors/therapeutic use; Alveolar Bone Loss/diagnostic imaging; Aminoquinolines/therapeutic use; Animals; Benzamides/therapeutic use; Bone Density; Female; Hydroxamic Acids/therapeutic use; Imaging, Three-Dimensional; Mice; Mice, Inbred BALB C; Olive Oil; Osteoclasts/pathology; Periodontitis/enzymology; Plant Oils/therapeutic use; Porphyromonas gingivalis; Pyridines/therapeutic use; X-Ray Microtomography

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Alveolar Bone Loss / Histone Deacetylase Inhibitors Limits: Animals Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Alveolar Bone Loss / Histone Deacetylase Inhibitors Limits: Animals Language: En Year: 2011 Type: Article